{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:11:30Z","timestamp":1782781890941,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08592-0","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T16:14:29Z","timestamp":1751645669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative performance and health economic analysis of prenatal screening for down syndrome in Fujian province, China"],"prefix":"10.1038","volume":"15","author":[{"given":"Lin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuolan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangpu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"8592_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7150\/ijms.2.91","volume":"2","author":"AE Czeizel","year":"2005","unstructured":"Czeizel, A. E. Birth defects are preventable. Int. J. Med. Sci. 2, 91\u201392. https:\/\/doi.org\/10.7150\/ijms.2.91 (2005).","journal-title":"Int. J. Med. Sci."},{"key":"8592_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.siny.2013.11.008","volume":"19","author":"V Kancherla","year":"2014","unstructured":"Kancherla, V., Oakley, G. P., Brent, R. L. & Jr, & Urgent global opportunities to prevent birth defects. Semin. Fetal Neonatal. Med. 19, 153\u2013160. https:\/\/doi.org\/10.1016\/j.siny.2013.11.008 (2014).","journal-title":"Semin Fetal Neonatal Med."},{"key":"8592_CR3","doi-asserted-by":"publisher","first-page":"04012","DOI":"10.7189\/jogh.14.04012","volume":"14","author":"XY Li","year":"2024","unstructured":"Li, X. Y. et al. The congenital birth defects burden in children younger than 14 years of age, 1990\u20132019: An age-period-cohort analysis of the global burden of disease study. J. Glob. Health. 14, 04012. https:\/\/doi.org\/10.7189\/jogh.14.04012 (2024).","journal-title":"J. Glob Health"},{"key":"8592_CR4","unstructured":"Ministry of Health of the People\u2019s Republic of China. National stocktaking report on birth defect prevention. Ministry of Health of the People\u2019s Republic of China. (2012). http:\/\/www.gov.cn\/gzdt\/att\/att\/site1\/20120912\/1c6f6506c7f811bacf9301.pdf. (2012)."},{"key":"8592_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis, S. E. et al. Down syndrome. Nat. Rev. Dis. Primers. 6, 9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"8592_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/GCO.0000000000000610","volume":"32","author":"M Neofytou","year":"2020","unstructured":"Neofytou, M. Predicting fetoplacental mosaicism during cfDNA-based NIPT. Curr. Opin. Obstet. Gynecol. 32, 152\u2013158. https:\/\/doi.org\/10.1097\/GCO.0000000000000610 (2020).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"8592_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/uog.17484","volume":"37","author":"TS Hartwig","year":"2017","unstructured":"Hartwig, T. S., Ambye, L., S\u00f8rensen, S. & J\u00f8rgensen, F. S. Discordant non-invasive prenatal testing (NIPT)\u2014a systematic review. Prenat Diagn. 37, 527\u2013539. https:\/\/doi.org\/10.1002\/uog.17484 (2017).","journal-title":"Prenat Diagn."},{"key":"8592_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil, M. M., Accurti, V., Santacruz, B., Plana, M. N. & Nicolaides, K. H. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis. Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound. Obstet. Gynecol. 50, 302\u2013314. https:\/\/doi.org\/10.1002\/uog.17484 (2017).","journal-title":"Ultrasound Obstet. Gynecol. Off J. Int. Soc. Ultrasound Obstet. Gynecol."},{"key":"8592_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/uog.14693","volume":"45","author":"MI Evans","year":"2015","unstructured":"Evans, M. I., Sonek, J. D., Hallahan, T. W. & Krantz, D. A. Cell-free fetal DNA screening in the USA: A cost analysis of screening strategies. Ultrasound Obstet. Gynecol. 45, 74\u201383. https:\/\/doi.org\/10.1002\/uog.14693 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"8592_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","volume":"182","author":"L Beulen","year":"2014","unstructured":"Beulen, L. et al. The consequences of implementing non-invasive prenatal testing in Dutch National health care: A cost-effectiveness analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 182, 53\u201361. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.08.028 (2014).","journal-title":"Eur J. Obstet. Gynecol. Reprod Biol."},{"key":"8592_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12962-020-00245-5","volume":"18","author":"L Nshimyumukiza","year":"2020","unstructured":"Nshimyumukiza, L., Beaumont, J. A., Rousseau, F. & Reinharz, D. Introducing cell-free DNA noninvasive testing in a down syndrome public health screening program: A budget impact analysis. Cost Effect Resour. Alloc. 18, 49. https:\/\/doi.org\/10.1186\/s12962-020-00245-5 (2020).","journal-title":"Cost Effect Resour. Alloc"},{"key":"8592_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/pd.4511","volume":"35","author":"BS Walker","year":"2015","unstructured":"Walker, B. S., Jackson, B. R., LaGrave, D., Ashwood, E. R. & Schmidt, R. L. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for down syndrome. Prenat Diagn. 35, 440\u2013446. https:\/\/doi.org\/10.1002\/pd.4511 (2015).","journal-title":"Prenat Diagn."},{"key":"8592_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3760\/cma.j.cn511374-20210512-00403","volume":"39","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. Retrospective and cost-effective analysis of the result of Changsha municipal public welfare program by noninvasive prenatal testing. Chin. J. Med. Genet. 39, 257\u2013263. https:\/\/doi.org\/10.3760\/cma.j.cn511374-20210512-00403 (2022).","journal-title":"Chin. J. Med. Genet."},{"key":"8592_CR14","unstructured":"National Health and Family Planning Commission Office. Notice of the general office of the national health and family planning commission on the standardization and orderly carrying out of prenatal screening and diagnosis of fetal free DNA in maternal peripheral blood. (2016). http:\/\/www.nhc.gov.cn\/fys\/s3581\/201611\/0e6fe5bac1664ebda8bc28ad0ed68389.shtml"},{"key":"8592_CR15","unstructured":"Zeng, F. An economic evaluation on prenatal screening strategies for Down\u2019s syndrome in Hunan Province. M.Sc. Thesis, Central South University. (2012). https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=CdHX_LbaUYyPCNM_5BJVgShm53-6iEV3uZSA0dvzU4i9CzEUsKOEtYsHPJX-VzR4JFRlzfShsK4AJeEDN5vBwIboKxOP4V9IJHtW_i9tNKI-FBEJOGopNZj22FSF9_pyODX_XkB3gPm-IdwWnRRki8fUN2ZvhqyinKEimsQlukHWQbgqn1z_zGdjZ3MiNjXkMLfjaZh2nZU=&uniplatform=NZKPT&language=CHS"},{"key":"8592_CR16","unstructured":"National Bureau of Statistics. China Statistical Year Book. China Statistics Press. (2023). https:\/\/www.stats.gov.cn\/sj\/ndsj\/2023\/indexch.htm"},{"key":"8592_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40246-020-00268-2","volume":"14","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Clinical performance of non-invasive prenatal screening as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot City in China. Hum. Genomics. 14, 21. https:\/\/doi.org\/10.1186\/s40246-020-00268-2 (2020).","journal-title":"Hum. Genomics"},{"key":"8592_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/14767051003758879","volume":"24","author":"C Irving","year":"2011","unstructured":"Irving, C., Richmond, S., Wren, C., Longster, C. & Embleton, N. D. Changes in fetal prevalence and outcome for trisomies 13 and 18: A population-based study over 23 years. J. Maternal-fetal Neonatal. Med. 24, 137\u2013141. https:\/\/doi.org\/10.3109\/14767051003758879 (2011).","journal-title":"J. maternal-fetal Neonatal Med."},{"key":"8592_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejogrb.2016.08.038","volume":"206","author":"A Kurtovic-Kozaric","year":"2016","unstructured":"Kurtovic-Kozaric, A. et al. Ten-year trends in prevalence of down syndrome in a developing country: Impact of the maternal age and prenatal screening. Eur. J. Obstet. Gynecol. Reprod. Biol. 206, 79\u201383. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.08.038 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"8592_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cca.2020.03.044","volume":"507","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects. Clin. Chim. Acta. 507, 125\u2013131. https:\/\/doi.org\/10.1016\/j.cca.2020.03.044 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"8592_CR21","doi-asserted-by":"publisher","first-page":"870543","DOI":"10.3389\/fpubh.2022.870543","volume":"10","author":"S Wang","year":"2022","unstructured":"Wang, S., Liu, K., Yang, H. & Ma, J. A cost-effectiveness analysis of screening strategies involving non-invasive prenatal testing for trisomy 21. Front. Public. Health. 10, 870543. https:\/\/doi.org\/10.3389\/fpubh.2022.870543 (2022).","journal-title":"Front. Public. Health"},{"key":"8592_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/S0266462319000308","volume":"35","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Cost-effectiveness analysis of non-invasive prenatal testing for down syndrome in China. Int J. Technol. Assess Health Care. 35, 237\u2013242. https:\/\/doi.org\/10.1017\/S0266462319000308 (2019).","journal-title":"Int J. Technol. Assess Health Care"},{"key":"8592_CR23","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3969\/ji.ssn.1673-5293.2021.10.025","volume":"32","author":"W Shang","year":"2021","unstructured":"Shang, W., Wan, Y. & Huang, J. Cross-sectional investigation on the utilization of prenatal screening and diagnostic services for down syndrome in China. Chin. J. Woman Child. Health Res. 32, 1529\u20131536. https:\/\/doi.org\/10.3969\/ji.ssn.1673-5293.2021.10.025 (2021).","journal-title":"Chin. J. Woman Child. Health Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08592-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08592-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T16:14:33Z","timestamp":1751645673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08592-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08592-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23940"}}